Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023 - Moseson, Dana E.; Tran, Trong Bien; Karunakaran, Bharathi; Ambardekar, Rohan; Hiew, Tze Ning (International journal of pharmaceutics: X, 2024)
Keywords: Amorphous solid dispersion; Dose; Drug product design; Patient centricity; Research Paper; Therapeutic category; FDA; Patient centricity; FDC; SAS; HBA; HBD; PVP; DP; Amorphous solid dispersion; LBF; SD; ASD; QD; Drug product design; EMA; BID; Dose; Therapeutic category; OM; MgSt; ON; HME; xPVP; cPT; SSG; SSF; MW; MCC; TID; BDDCS; DCP; CCS; BCS; PEG; USP; RESS; SCF; HPMCAS; Ro5; HPC; PVA; PVPVA; bRo5; DPI; GRAS; L-HPC; HPMC